https://fundaeher.org.do/aviso/2024-04-17T12:11:08-04:00https://fundaeher.org.do/aviso-2/2024-04-17T12:17:18-04:00https://fundaeher.org.do/una-terapia-crispr-previene-los-sintomas-del-angioedema-hereditario/2024-05-07T12:28:44-04:00https://fundaeher.org.do/perspectivas-de-2024-para-el-diagnostico-y-tratamiento-de-las-enfermedades-raras/2024-05-07T12:32:04-04:00https://fundaeher.org.do/una-terapia-genetica-restaura-el-desarrollo-y-la-funcion-en-celulas-de-personas-con-sindrome-de-timothy/2024-05-07T12:37:57-04:00https://fundaeher.org.do/farmaco-prometedor-para-frenar-la-progresion-de-una-enfermedad-genetica-rara-y-dolorosa/2024-05-07T12:46:33-04:00https://fundaeher.org.do/la-fda-aprueba-un-farmaco-para-el-tratamiento-de-la-distrofia-muscular-de-duchenne/2024-05-07T12:48:59-04:00https://fundaeher.org.do/urticaria-cronica-cuando-hasta-tu-propio-sudor-te-produce-alergia/2024-05-07T12:55:14-04:00https://fundaeher.org.do/los-riesgos-raros-de-trombosis-de-la-vacuna-de-astrazeneca-contra-el-covid-se-conocian-desde-2021/2024-05-07T12:59:30-04:00https://fundaeher.org.do/que-es-el-angioedema-por-deficiencia-del-inhibidor-de-c1/2024-05-07T13:09:32-04:00https://fundaeher.org.do/primera-terapia-de-arn-mensajero-para-una-enfermedad-rara-la-acidemia-propionica/2024-05-07T13:12:45-04:00https://fundaeher.org.do/pint-pharma-anuncia-la-aprobacion-de-orladeyo-berotralstat-la-primera-terapia-oral-indicada-para-prevenir-los-ataques-de-angioedema-hereditario-hae-en-pacientes-adultos-y-pediatricos-de-12/2024-05-07T13:35:13-04:00https://fundaeher.org.do/el-7-de-mayo-os-esperamos-en-murcia-para-celebrar-el-ix-foro-de-enfermedades-raras-y-sin-diagnostico/2024-05-07T13:43:09-04:00https://fundaeher.org.do/el-angioedema-hereditario-la-enfermedad-rara-que-tarda-13-anos-en-diagnosticarse/2024-05-07T13:52:58-04:00https://fundaeher.org.do/firazyr-uno-de-los-farmacos-mas-rapidos-en-actuar-en-las-crisis-agudas-de-angiodema/2024-05-07T14:03:42-04:00https://fundaeher.org.do/la-terapia-genica-con-crispr-in-vivo-abre-paso-a-la-curacion-del-angioedema-hereditario/2024-05-07T14:29:57-04:00https://fundaeher.org.do/perspectiva-del-mercado-de-angioedema-hereditario-terapeutico-en-america-latina/2024-05-07T14:41:52-04:00https://fundaeher.org.do/berotralstat-en-angioedema-hereditario/2024-05-07T14:48:14-04:00https://fundaeher.org.do/16-de-mayo-dia-mundial-del-angioedema-hereditario/2024-05-07T14:55:02-04:00https://fundaeher.org.do/una-terapia-genetica-logra-curar-el-angioedema-una-dolorosa-enfermedad-hereditaria/2024-05-07T15:08:07-04:00https://fundaeher.org.do/expandiendo-la-familia/2024-05-08T11:57:14-04:00https://fundaeher.org.do/que-especialista-trata-el-angioedema/2024-05-08T12:08:34-04:00https://fundaeher.org.do/angioedema-hereditario-y-adquirido/2024-05-08T12:16:22-04:00https://fundaeher.org.do/anvisa-aprueba-berotralstat-para-la-profilaxis-del-aeh-en-brasil/2024-05-13T14:02:29-04:00https://fundaeher.org.do/tratamiento-profilactico-para-adolescentes-con-aeh-opinion-de-expertos/2024-05-13T14:23:56-04:00https://fundaeher.org.do/como-el-aeh-puede-afectar-la-neurologia-y-la-psicologia-de-los-pacientes/2024-05-13T14:42:49-04:00https://fundaeher.org.do/comprender-las-necesidades-de-calidad-de-vida-de-los-pacientes-con-aeh/2024-05-13T14:46:33-04:00https://fundaeher.org.do/evaluacion-de-la-eficacia-de-la-profilaxis-con-inhibidores-de-c1-para-tratar-el-aeh/2024-05-13T14:49:35-04:00https://fundaeher.org.do/mientras-la-guerra-continua-en-la-cercana-gaza-un-experto-israeli-continua-tratando-a-pacientes-con-aeh/2024-05-13T14:55:02-04:00https://fundaeher.org.do/el-tratamiento-del-aeh-con-un-vector-aav8-dx88-hsa-demuestra-eficacia/2024-05-14T09:44:45-04:00https://fundaeher.org.do/biocryst-presenta-nueva-evidencia-del-mundo-real-que-muestra-reducciones-significativas-en-la-utilizacion-de-recursos-sanitarios-entre-pacientes-con-aeh-tras-el-inicio-de-orladeyo-berotralstat/2024-05-21T14:51:27-04:00https://fundaeher.org.do/mexico-pint-pharma-anuncia-la-aprobacion-de-orladeyo-berotralstat-la-primera-terapia-oral-indicada-para-prevenir-los-ataques-de-angioedema-hereditario-hae-en-pacientes-adultos-y-pediatrico/2024-05-21T15:36:16-04:00https://fundaeher.org.do/hacia-el-control-total-del-angioedema-hereditario/2024-06-10T10:26:18-04:00https://fundaeher.org.do/mas-del-90-de-las-enfermedades-minoritarias-tienen-un-origen-genetico-y-el-65-son-graves-invalidantes-y-complejas/2024-06-10T10:33:25-04:00https://fundaeher.org.do/celine-dion-habla-por-primera-vez-de-su-dura-enfermedad-aunque-espero-un-milagro-de-la-ciencia-debo-aprender-a-vivir-con-ella/2024-06-10T10:40:18-04:00https://fundaeher.org.do/insomnio-familiar-fatal-la-enfermedad-ultrarrara-que-se-ceba-con-un-pueblo-de-jaen-se-expande-por-el-cerebro-como-una-bomba/2024-06-10T10:51:33-04:00https://fundaeher.org.do/estas-son-las-enfermedades-raras-mas-comunes-en-rd/2024-06-10T10:53:49-04:00https://fundaeher.org.do/enfermedades-raras-en-republica-dominicana-retos-y-oportunidades/2024-06-10T10:57:45-04:00https://fundaeher.org.do/que-son-las-enfermedades-autoinmunes/2024-07-08T11:06:37-04:00https://fundaeher.org.do/mejora-significativa-en-el-tratamiento-del-angioedema-hereditario/2024-07-08T15:32:58-04:00https://fundaeher.org.do/muere-una-nina-de-10-anos-cuya-historia-se-hizo-viral-en-tiktok/2024-07-16T15:09:38-04:00https://fundaeher.org.do/ministerio-de-salud-y-primera-dama-anuncian-ampliacion-de-horario-del-centro-de-contacto-cuida-tu-salud-mental/2024-07-29T12:23:42-04:00https://fundaeher.org.do/donidalorsen-reduce-hasta-un-81-la-tasa-mensual-de-crisis-en-angioedema-hereditario/2024-08-20T11:03:00-04:00https://fundaeher.org.do/el-hospital-gregorio-maranon-acreditado-como-centro-de-referencia-internacional-en-angiodema-y-urticaria/2024-08-20T11:10:05-04:00https://fundaeher.org.do/hay-cada-vez-mas-enfermedades-los-tres-complejos-factores-que-desafian-hoy-a-la-salud-y-la-advertencia-de-los-expertos/2024-08-26T14:32:32-04:00https://fundaeher.org.do/que-es-el-sindrome-de-turner-la-condicion-que-afecta-exclusivamente-a-las-mujeres/2024-08-28T12:05:08-04:00https://fundaeher.org.do/foro-global-de-angioedema-acare-2024-gaf-4-de-octubre-5-de-octubre/2024-09-09T12:52:13-04:00https://fundaeher.org.do/bellvitge-contribuye-a-una-mejora-significativa-en-el-tratamiento-del-angioedema-hereditario/2024-11-25T15:49:31-04:00https://fundaeher.org.do/sebetralstat-oral-para-el-tratamiento-de-ataques-agudos-de-angioedema-hereditario/2024-11-25T15:56:38-04:00https://fundaeher.org.do/avances-en-el-tratamiento-del-angioedema-herediario-aeh/2024-11-25T16:09:38-04:00https://fundaeher.org.do/depositan-anteproyecto-de-ley-que-busca-transformar-la-atencion-a-pacientes-con-enfermedades-raras/2025-03-25T16:02:24-04:00https://fundaeher.org.do/atencion-a-las-enfermedades-raras/2025-03-27T10:42:31-04:00https://fundaeher.org.do/una-de-cada-50-000-personas-en-el-mundo-padece-angioedema-hereditario-una-enfermedad-minoritaria-y-potencialmente-mortal/2025-05-16T11:24:30-04:00https://fundaeher.org.do/16-de-mayo-dia-mundial-del-angioedema-hereditario-aeh/2025-05-16T11:27:47-04:00https://fundaeher.org.do/orladeyo-berotralstat/2025-05-30T10:16:33-04:00https://fundaeher.org.do/la-oms-declara-a-las-enfermedades-raras-como-prioridad-mundial-de-salud-publica/2025-06-25T14:52:44-04:00https://fundaeher.org.do/dia-mundial-del-vitiligo-visibilizar-educar-y-apoyar-sin-prejuicios/2025-06-25T14:57:46-04:00https://fundaeher.org.do/que-son-las-celulas-t-las-guardias-de-seguridad-del-sistema-inmunologico-cuyo-descubrimiento-fue-premiado-con-el-nobel-de-medicina-2025/2025-10-08T15:00:15-04:00https://fundaeher.org.do/sindrome-de-sjogren/2025-11-07T10:11:20-04:00https://fundaeher.org.do/que-es-la-afasia-sintomas-causas-y-tipos-de-afasia/2025-11-07T10:17:14-04:00https://fundaeher.org.do/enfermedad-de-alzheimer/2025-11-07T10:24:56-04:00https://fundaeher.org.do/nuevos-datos-sobre-la-eficacia-del-sebetralstat-en-ninos-y-adultos-seran-presentados-en-una-importante-conferencia-mundial/2025-11-07T11:11:02-04:00https://fundaeher.org.do/datos-sobre-el-inhibidor-de-la-esterasa-c1-recombinante-como-tratamiento-para-hae-que-se-presentara-en-la-reunion-cientifica-anual-de-acaai-de-2025/2025-11-07T11:20:54-04:00https://fundaeher.org.do/hae-el-especialista-en-medicina-biocryst-compra-la-compania-farmaceutica-astria-therapeutics-para-fortalecer-aun-mas-su-presencia-en-hae/2025-11-07T11:30:51-04:00https://fundaeher.org.do/madrid-sera-sede-de-la-conferencia-global-de-liderazgo-en-angioedema-2026-bajo-el-lema-marca-la-diferencia/2026-03-05T12:34:29-04:00https://fundaeher.org.do/entrevista-la-receta-medica-de-la-z-dia-mundial-de-angioedema-hereditario-javier-santana-dra-linda-medina-y-andry-batista-fundaeher/2026-05-20T11:14:03-04:00https://fundaeher.org.do/descubren-como-posible-farmaco-para-tratar-el-lupus-podria-frenar-el-cancer-cerebral-mas-agresivo/2026-05-20T15:11:57-04:00